Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

|Videos|March 24, 2023

Insights into Acne Management and Treatment Selection

Author(s)Linda Stein Gold, MD, Neal Bhatia, MD

Linda Stein-Gold, MD and Neal Bhatia, MD discuss their approach to acne management highlighting the novel utility of clascoterone cream 1% and where this fits into their treatment regimens.

Episodes in this series

EP. 1 Expert Perspective on the Clinical Management of Acne Vulgaris

EP. 1 Expert Perspective on the Clinical Management of Acne Vulgaris

EP. 2 Adapting Acne Management to Changing Patient Characteristics

EP. 2 Adapting Acne Management to Changing Patient Characteristics

EP. 3 Overview of Pediatric and Adult Acne Management

EP. 3 Overview of Pediatric and Adult Acne Management

EP. 4 Treatment Dosing Considerations in Pediatric Patients

EP. 4 Treatment Dosing Considerations in Pediatric Patients

EP. 5 Optimal Use Cases for Clascoterone Cream 1%

EP. 5 Optimal Use Cases for Clascoterone Cream 1%

EP. 6 Insights into Acne Management and Treatment Selection

EP. 6 Insights into Acne Management and Treatment Selection

EP. 7 Understanding Dosing Requirements with Isotretinoin

EP. 7 Understanding Dosing Requirements with Isotretinoin

EP. 8 Frontline Forum Part 1: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 8 Frontline Forum Part 1: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 9 Frontline Forum Part 2: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 9 Frontline Forum Part 2: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 10 Frontline Forum Part 3: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 10 Frontline Forum Part 3: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 11 Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 11 Frontline Forum Part 4: Exploring Expert Perspectives on the Management of Acne Vulgaris

EP. 12 Discovering Dermatology Times: June 2023 Acne Supplement

EP. 12 Discovering Dermatology Times: June 2023 Acne Supplement

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Narrow-Spectrum Sarecycline Approved for Moderate to Severe Acne in China

ByMarie Bosslett, Assistant Editor

February 3rd 2026

Fractional CO₂ Resurfacing Improves Acne Scarring in Middle Eastern Patients

ByMaddi Hebebrand, MC, Associate Editor

February 2nd 2026

Dermatology Times Spot Test: February 1, 2026

ByMarie Bosslett, Assistant Editor

February 1st 2026

On the Horizon: Innovations in the Acne Treatment Pipeline

ByHeidi Anne Duerr, MPH

January 28th 2026

New Research Highlights Significant Knowledge Gaps in Patients Using Oral Acne Medication

ByMarie Bosslett, Assistant Editor

January 21st 2026

Latest CME

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

In-Person Event

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

February 7, 2026

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Trending on Dermatology Times

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review

Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older

Introducing Dermatology Times NP/PA Connect

FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA